Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy

被引：12
|
作者：
Whittington, Melanie D. [1 ]
Ollendorf, Daniel A. [2 ]
Campbell, Jonathan D. [1 ]
机构：
[1] Univ Colorado, Anschutz Med Campus,12850 E Montview Blvd, Aurora, CO 80045 USA
[2] Inst Clin & Econ Review, Boston, MA USA
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 12期
关键词：
D O I：
10.1001/jamaoncol.2018.4625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1784 / 1785
页数：5
相关论文
共 50 条
  • [21] Chimeric Antigen Receptor T-Cell Therapy
    Rasheed, Azgar Abdul
    Koyyala, Venkata Pradeep Babu
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 89 - 92
  • [22] Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
    Brown, Kevin
    Seftel, Matthew D.
    Hay, Kevin A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (33) : E1300 - E1302
  • [23] COST OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY RELATED TOXICITIES
    Patel, N.
    Farid, S.
    Gomes, M.
    VALUE IN HEALTH, 2023, 26 (12) : S196 - S196
  • [24] Atypical Cerebrospinal Fluid Cytology Findings in Chimeric Antigen Receptor T-cell Immunotherapy
    Wubneh, Helmae
    Roth, Mark
    Filie, Armando
    Shah, Nirali
    Wang, Hao-Wei
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 441 - 441
  • [25] A Concise Review of Neurologic Complications Associated with Chimeric Antigen Receptor T-cell Immunotherapy
    Ruff, Michael W.
    Siegler, Elizabeth L.
    Kenderian, Saad S.
    NEUROLOGIC CLINICS, 2020, 38 (04) : 953 - 963
  • [26] Chimeric Antigen Receptor T-cell Immunotherapy and Need for Prophylaxis for Invasive Mold Infections
    Lewis, Russell E.
    Kontoyiannis, Dimitrios P.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (07) : 1802 - 1803
  • [27] Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy A Review
    Ventin, Marco
    Cattaneo, Giulia
    Maggs, Luke
    Arya, Shahrzad
    Wang, Xinhui
    Ferrone, Cristina R.
    JAMA ONCOLOGY, 2024, 10 (01) : 115 - 121
  • [28] Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
    Zhang, Peng
    Zhang, Yang
    Ji, Nan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Atypical Cerebrospinal Fluid Cytology Findings in Chimeric Antigen Receptor T-cell Immunotherapy
    Wubneh, Helmae
    Roth, Mark
    Filie, Armando
    Shah, Nirali
    Wang, Hao-Wei
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 441 - 441
  • [30] Chimeric Antigen Receptor T Cell Based Immunotherapy for Cancer
    Li, Feng
    Zhang, Tengfei
    Cao, Ling
    Zhang, Yi
    CURRENT STEM CELL RESEARCH & THERAPY, 2018, 13 (05) : 327 - 335
12345